We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A district court judge granted GlaxoSmithKline’s (GSK) motion for a preliminary injunction, stopping a new rule on patent claims and continuations from going into effect Nov. 1.